Gene Identifier: In Arabidopsis, "At3g57940" could refer to a gene encoding a protein of unknown function. Antibodies developed against such proteins are typically used in plant molecular biology to study gene expression, localization, or protein-protein interactions.
Miscommunication: The term may be a misprint or confusion with "At3g57940" (e.g., a gene involved in RNA processing, as seen in similar identifiers like AtMTR4 ).
While the search results focus on human and animal antibodies, plant-specific antibodies are less commonly documented. Key insights from related sources:
Lack of Data: No specific antibody targeting "At3g57940" is described in the sources. This suggests the antibody may be proprietary, experimental, or misidentified.
Next Steps:
Verify the gene identifier for accuracy (e.g., check the Arabidopsis genome database).
Consult plant biology databases (e.g., TAIR, UniProt) for antibody availability.
Contact specialized antibody manufacturers for custom synthesis if the target is confirmed.
For context, the search results highlight antibodies in human medicine (e.g., Nipocalimab for autoimmune diseases) and plant RNA helicases (e.g., AtMTR4 and HEN2) . These examples illustrate the diversity of antibody applications but do not address plant-specific antibodies like "At3g57940."
At3g57940 is a gene located on chromosome 3 of Arabidopsis thaliana (Mouse-ear cress) that encodes a GNAT acetyltransferase containing a domain of unknown function (DUF699). This protein is also known as RNA cytidine acetyltransferase 2 or 18S rRNA cytosine acetyltransferase 2 with the UniProt identifier Q9M2Q4. The enzyme belongs to the EC 2.3.1.- class and functions in RNA modification processes, specifically in the acetylation of cytosine residues in ribosomal RNA. Understanding the structural and functional characteristics of this protein is essential for designing experiments using At3g57940 antibodies and interpreting results in the context of RNA metabolism in plants.
Currently, researchers can access both polyclonal and monoclonal antibodies against At3g57940. Commercially available options include:
Rabbit polyclonal antibodies against Arabidopsis thaliana At3g57940, which recognize multiple epitopes of the target protein
Mouse monoclonal antibodies targeting the N-terminus of the Q9M2Q4 protein (At3g57940)
Each antibody type offers distinct advantages - polyclonal antibodies typically provide stronger signals by recognizing multiple epitopes but may exhibit higher background, while monoclonal antibodies offer increased specificity for particular protein domains or conformations but potentially lower sensitivity. The choice between these should be guided by specific experimental requirements and validation data.
At3g57940 antibodies have been validated for several research applications:
| Application | Validated Antibody Types | Recommended Dilution | Detection Range |
|---|---|---|---|
| Western Blot (WB) | Rabbit polyclonal, Mouse monoclonal | 1:1000 | 0.01-1 ng of target protein |
| ELISA | Rabbit polyclonal, Mouse monoclonal | 1:10,000 | Down to 1 ng detection |
| Immunoprecipitation (IP) | Selected antibody packages | As recommended | Varies by protocol |
For Western blotting, antibodies can detect the native protein in plant extracts, ensuring identification of the correct antigen. ELISA applications demonstrate high titer antibody-antigen interactions. It's crucial to validate any antibody in your specific experimental system before conducting full-scale experiments, as performance can vary across different sample preparations and detection methods.
A comprehensive validation strategy for At3g57940 antibodies should include:
Positive controls: Use recombinant At3g57940 protein or extracts from tissues known to express the protein at detectable levels.
Negative controls: Include extracts from At3g57940 knockout or knockdown Arabidopsis lines, if available. Alternatively, use closely related plant species where the epitope sequence differs significantly.
Specificity tests: Perform peptide competition assays where pre-incubation of the antibody with its specific antigen peptide should abolish or significantly reduce signal.
Dilution optimization: Test a range of antibody concentrations (starting from 1:500 to 1:5000) to determine the optimal signal-to-noise ratio for your specific application and detection system.
Cross-reactivity assessment: Evaluate potential cross-reactivity with other GNAT family acetyltransferases, particularly those with high sequence homology to At3g57940.
These validation steps are essential to ensure reliable and reproducible results, especially when working with previously uncharacterized antibodies or when adapting antibodies to new experimental systems.
For efficient extraction and detection of At3g57940 from Arabidopsis tissues, consider the following protocol:
Harvest fresh plant material and immediately flash-freeze in liquid nitrogen.
Grind tissue to a fine powder while maintaining freezing conditions to prevent protein degradation.
Extract proteins using a buffer containing:
50 mM Tris-HCl (pH 7.4-7.5)
150 mM NaCl
1% non-ionic detergent (e.g., Triton X-100)
1 mM EDTA
Protease inhibitor cocktail
Maintain cold temperatures (4°C) throughout the extraction process to minimize protein degradation.
Clear the lysate by centrifugation at 14,000 × g for 15 minutes at 4°C.
Quantify protein concentration using Bradford or BCA assay before proceeding to immunodetection.
For subcellular localization studies, consider fractionation techniques to enrich for particular cellular compartments based on the predicted localization of At3g57940. The extraction method should be optimized based on whether you're targeting soluble or membrane-associated forms of the protein.
When encountering non-specific binding with At3g57940 antibodies, implement these troubleshooting strategies:
Increase blocking stringency:
Extend blocking time to 2 hours at room temperature
Increase blocking agent concentration to 5% BSA or milk
Consider testing alternative blocking agents (BSA vs. milk) as performance can vary between antibodies
Optimize antibody conditions:
Dilute primary antibody further (test 1:2000 to 1:5000 for Western blots)
Reduce incubation temperature from room temperature to 4°C
Add 0.1-0.5% Tween-20 to washing and antibody incubation buffers
Reduce background:
For polyclonal antibodies, consider antigen-affinity purification as used for the commercial rabbit anti-At3g57940 antibody
Pre-absorb antibodies with extracts from tissues not expressing the target
Perform peptide competition controls to confirm signal specificity
Adjust electrophoresis conditions:
To investigate protein complexes involving At3g57940:
Co-immunoprecipitation (Co-IP):
Use At3g57940 antibodies conjugated to protein A/G beads
Extract proteins under native conditions to preserve interactions
Elute bound proteins and identify partners by Western blot or mass spectrometry
Include appropriate controls (IgG control, input samples)
Protein complex stabilization:
Apply recent innovations in antibody generation for protein complexes, as demonstrated by the BTLA-HVEM fusion protein approach
Consider chemical crosslinking prior to immunoprecipitation to stabilize transient interactions
Create fusion constructs that stabilize At3g57940 with its interaction partners for improved complex detection
In situ detection:
Use proximity ligation assay (PLA) to visualize protein interactions within plant cells
Perform immunofluorescence co-localization studies with antibodies against suspected interaction partners
This approach allows for comprehensive mapping of the At3g57940 interactome, providing insights into its functional roles in RNA modification pathways and potential regulatory interactions.
To investigate post-translational modifications (PTMs) of At3g57940:
Modification-specific detection:
Perform immunoprecipitation with At3g57940 antibodies followed by Western blotting with antibodies against specific PTMs (phosphorylation, acetylation, etc.)
Use Phos-tag™ acrylamide gels to separate and detect phosphorylated forms
Consider 2D gel electrophoresis to separate protein isoforms based on charge differences resulting from PTMs
Enzymatic verification:
Treat samples with phosphatases, deacetylases, or other PTM-removing enzymes to confirm modification identity
Compare migration patterns before and after treatment
Comprehensive PTM mapping:
Combine immunoprecipitation using At3g57940 antibodies with mass spectrometry analysis
Look for mass shifts indicative of specific modifications
Generate a PTM profile across different developmental stages or environmental conditions
Since At3g57940 functions as an acetyltransferase, investigating its own regulation through PTMs may provide insights into feedback mechanisms controlling RNA modification in plants.
If investigating potential chromatin associations of At3g57940:
Experimental design considerations:
Determine whether At3g57940 directly interacts with chromatin or functions in RNA modification pathways
For direct DNA interactions, use appropriate crosslinking conditions (1% formaldehyde for 10-15 minutes)
Optimize sonication to generate 200-500 bp DNA fragments
ChIP protocol adaptation:
Use at least 5-10 μg of antibody per ChIP reaction
Include appropriate controls: IgG control, input sample, and positive control antibodies (e.g., anti-histone)
For plants, consider using native ChIP (without crosslinking) for some applications
Validation and analysis:
Validate ChIP results with ChIP-qPCR before proceeding to sequencing
If signal is weak, consider using ChIP-exo or ChIP-nexus for higher resolution
For direct At3g57940-DNA interactions, validate with in vitro binding assays
While At3g57940 is primarily characterized as an RNA modification enzyme, investigating potential chromatin associations could reveal novel functions in transcriptional regulation or RNA processing.
Adapting At3g57940 antibodies for single-cell research requires:
Signal amplification strategies:
Consider tyramide signal amplification (TSA) to enhance detection sensitivity
Utilize brighter fluorophores and optimized filter sets for improved signal-to-noise ratio
Evaluate quantum dots or other nanoparticle conjugates for increased photostability
Tissue preparation optimization:
Develop gentle cell isolation protocols that preserve protein epitopes
Optimize fixation conditions to maintain cellular architecture while enabling antibody access
Implement appropriate clearing techniques to reduce autofluorescence common in plant tissues
Integration with single-cell technologies:
Combine immunofluorescence with laser capture microdissection for targeted cell analysis
Explore compatibility with emerging plant single-cell analysis platforms
Consider mass cytometry (CyTOF) with metal-conjugated antibodies for multi-parameter cellular analysis
These approaches could reveal cell-type-specific roles of At3g57940 in RNA modification across different plant tissues and developmental stages.
Integrating computational methods can advance At3g57940 antibody research through:
Epitope prediction and antibody design:
Utilize structure prediction algorithms to model At3g57940 tertiary structure
Identify optimal epitopes based on accessibility, uniqueness, and conservation
Design synthetic peptides for generating highly specific antibodies
Cross-reactivity analysis:
Perform in silico analysis of potential cross-reactivity with related GNAT family proteins
Predict potential off-target binding across the Arabidopsis proteome
Identify conserved epitopes across species for cross-species applications
Data integration and analysis:
Develop automated image analysis pipelines for quantitative immunofluorescence
Implement machine learning approaches for pattern recognition in complex localization data
Integrate antibody-derived data with transcriptomic and proteomic datasets for systems-level analysis
These computational approaches can help address challenges in antibody specificity and application optimization, particularly for proteins like At3g57940 that belong to larger enzyme families with conserved domains.